Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 22 Oct 21 424B4 Prospectus supplement with pricing info
- 22 Oct 21 EFFECT Notice of effectiveness
- 20 Oct 21 S-1/A IPO registration (amended)
-
18 Oct 21 S-1/A IPO registration (amended)
- 1 Oct 21 S-1 IPO registration
XLO similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated May 24, 2021 (except Note 18(f), as to which the date is October 18, 2021) in Amendment 1 to the Registration Statement (Form S-1 No. 333-259973) and the related Prospectus of Xilio Therapeutics, Inc. for the registration of shares of its common stock.
/s/ Ernst & Young LLP
Boston, Massachusetts
October 18, 2021